Loading
Anorectal Disease Treatments and Outcomes / Diverticular Disease and Complications · Review
Frontiers in Oncology · September 7, 2026
A consensus or society position rather than new primary data.
This narrative review identifies three established surgical options (Martius flap, graciloplasty, delayed coloanal anastomosis) for radiation-induced rectovaginal fistula but acknowledges that the overall certainty of available evidence is low, with most supporting data derived from heterogeneous non-RI-RVF populations or indirect comparisons. The evidence base is inadequate to define a universally accepted treatment standard or to validate selection criteria such as the 1.5 cm threshold for Martius flap eligibility.
Narrative review. Literature on treatment of radiation-induced rectovaginal fistula, predominantly following gynaecological malignancy treatment. Of 70 publications cited, 26 constitute the clinical evidence base; 44 provided anatomical, radiotherapeutic, methodological or background context.. Intervention: Surgical and conservative management options including faecal diversion, Martius flap, gracilis interposition, delayed coloanal anastomosis, and stromal vascular fraction..
Spontaneous closure after faecal diversion alone is uncommon: 6/50 (12%) patients achieved closure without additional intervention Gracilis interposition meta-analytic data derive from heterogeneous perineal fistula cohorts in which only approximately 18% of patients had received radiotherapy Delayed coloanal anastomosis showed fewer anastomotic complications than immediate anastomosis in low rectal cancer meta-analyses, though not consistently across endpoints
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize that Martius flap, graciloplasty, and delayed coloanal anastomosis are established options, but the quality of evidence is low and largely indirect. Treatment selection cannot yet be guided by rigorous comparative data specific to radiation-induced fistula. Outcome reporting should extend beyond anatomical closure to include stoma-free survival, functional recovery, and patient-reported quality of life.
A narrative review synthesizing heterogeneous evidence on treatment options for radiation-induced rectovaginal fistula, offering clinical guidance but acknowledging low overall certainty and lack of direct evidence from RI-RVF populations for most interventions.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should recognize that Martius flap, graciloplasty, and delayed coloanal anastomosis are established options, but the quality of evidence is low and largely indirect. Treatment selection cannot yet be guided by rigorous comparative data specific to radiation-induced fistula. Outcome reporting should extend beyond anatomical closure to include stoma-free survival, functional recovery, and patient-reported quality of life.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Introduction Radiation-induced rectovaginal fistula (RI-RVF) is a severe late complication of pelvic radiotherapy, arising predominantly after treatment for gynaecological malignancy and characterised by fibrosis, ischaemia, impaired healing and poor quality of life. No universally accepted treatment standard exists. Methods A structured narrative review searched PubMed and Google Scholar (January 2020–July 2026), with earlier landmark studies identified through reference-list screening; it was not conducted or reported as a systematic review. Eight reviewers screened records singly rather than in duplicate, with uncertain cases resolved by consensus with two senior supervisors. Predefined outcome domains beyond anatomical closure were extracted, including stoma-free survival, continence, low anterior resection syndrome, sexual function, pelvic pain and patient-reported quality of life. Seventy publications were cited, of which 26 constitute the clinical evidence base; the remaining 44 provided anatomical, radiotherapeutic, methodological or background context. Results Faecal diversion is an appropriate initial, bridging or palliative intervention rather than a universal first-line treatment; spontaneous closure after diversion alone is uncommon (6/50; 12%), and colostomy and ileostomy carry distinct complication profiles. The Martius flap is applied mainly to low fistulas with small defects; the quoted 1.5 cm threshold reflects selection criteria in published series rather than a validated cut-off, and larger defects have been repaired successfully. Gracilis interposition is used for complex or recurrent fistulas, although supporting meta-analytic data derive from heterogeneous perineal fistula cohorts in which only approximately 18% of patients had received radiotherapy. Delayed coloanal anastomosis was associated with fewer anastomotic complications than immediate anastomosis in low rectal cancer meta-analyses, though not consistently across endpoints; this evidence does not derive from RI-RVF populations. Functional and patient-reported outcomes were reported inconsistently, with non-comparable instruments. Evidence for stromal vascular fraction is confined to case reports and small series. Conclusions The overall certainty of the available evidence is low. Martius flap reconstruction, graciloplasty and delayed coloanal anastomosis are established options, but reported efficacy must be interpreted against the heterogeneity and indirectness of the available evidence. Stromal vascular fraction remains experimental. Prospective studies should redefine success beyond anatomical closure to include stoma-free survival, functional recovery and patient-reported quality of life.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.